Amos Akintayo Fatokun (Amos A Fatokun)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 11

Top Venues

Pharmaceuticals (Basel, Switzerland)

BMC complementary medicine and therapies

Exploration of targeted anti-tumor therapy

SLAS technology

University of Glasgow (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Glasgow Oct 01 2003 - Jun 23 2006

United Kingdom

PHD

Publications

Marwan Algellay, Matthew Roberts, Lucy A Bosworth, Satyajit Dey Sarker, Amos Akintayo Fatokun, Touraj Ehtezazi
The Use of Micro-Ribbons and Micro-Fibres in the Formulation of 3D Printed Fast Dissolving Oral Films. Pharmaceuticals (Basel, Switzerland) 16 (1) (2023)
Babatunde E Ajayi, Bola Oboh, Joseph B Minari, Darren W Sexton, Satyajit Dey Sarker, Amos Akintayo Fatokun
Cola rostrata K. Schum. constituents induce cytotoxicity through reactive oxygen species generation and mitochondrial membrane depolarisation. Exploration of targeted anti-tumor therapy 4 (6) (2023)
Marwan Algellay, Matthew Roberts, Lucy A Bosworth, Satyajit Dey Sarker, Amos Akintayo Fatokun, Touraj Ehtezazi
The Use of Micro-Ribbons and Micro-Fibres in the Formulation of 3D Printed Fast Dissolving Oral Films. Pharmaceuticals (Basel, Switzerland) 16 (1) (2023)
Babatunde E Ajayi, Bola Oboh, Joseph B Minari, Darren W Sexton, Satyajit Dey Sarker, Amos Akintayo Fatokun
Cola rostrata K. Schum. constituents induce cytotoxicity through reactive oxygen species generation and mitochondrial membrane depolarisation. Exploration of targeted anti-tumor therapy 4 (6) (2023)
Abdulhakeem O Sulyman, Jessie Fulcher, Samuel Crossley, Amos Akintayo Fatokun, Femi J Olorunniji
Shikonin and Juglone Inhibit Mycobacterium tuberculosis Low-Molecular-Weight Protein Tyrosine Phosphatase a (Mt-PTPa). Biotech (Basel (Switzerland)) 12 (3) (2023)
Marwan Algellay, Matthew Roberts, Lucy A Bosworth, Satyajit Dey Sarker, Amos Akintayo Fatokun, Touraj Ehtezazi
The Use of Micro-Ribbons and Micro-Fibres in the Formulation of 3D Printed Fast Dissolving Oral Films. Pharmaceuticals (Basel, Switzerland) 16 (1) (2023)
Temidayo D Popoola, Peter A Segun, Edmund Ekuadzi, Rita Akosua Dickson, Olanrewaju R Awotona, Lutfun Nahar, Satyajit Dey Sarker, Amos Akintayo Fatokun
West African medicinal plants and their constituent compounds as treatments for viral infections, including SARS-CoV-2/COVID-19. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 30 (1) (2022)
Bamigboye J Taiwo, Temidayo D Popoola, Fanie R van Heerden, Amos Akintayo Fatokun
Isolation and Characterisation of Two Quercetin Glucosides with Potent Anti-Reactive Oxygen Species (ROS) Activity and an Olean-12-en Triterpene Glucoside from the Fruit of Abelmoschus esculentus (L.) Moench. Chemistry & biodiversity 18 (1) (2021)
Temidayo D Popoola, Stephanie T Guetchueng, Kenneth J Ritchie, Olufunsho Awodele, Nicola M Dempster, Oluyemi Akinloye, Satyajit D Sarker, Amos Akintayo Fatokun
Potent Nrf2-inducing, antioxidant, and anti-inflammatory effects and identification of constituents validate the anti-cancer use of Uvaria chamae and Olax subscorpioidea. BMC complementary medicine and therapies 21 (1) (2021)
Bamigboye J Taiwo, Temidayo D Popoola, Fanie R van Heerden, Amos Akintayo Fatokun
Pentagalloylglucose, isolated from the leaf extract of Anacardium occidentale L., could elicit rapid and selective cytotoxicity in cancer cells. BMC complementary medicine and therapies 20 (1) (2020)
Sunday Olakunle Idowu, Amos Akintayo Fatokun
Artificial Intelligence (AI) to the Rescue: Deploying Machine Learning to Bridge the Biorelevance Gap in Antioxidant Assays. SLAS technology 26 (1) (2020)

Amos Akintayo Fatokun.css-eqlu8i{font-size:small;padding-left:4px;} (Amos A Fatokun)

Publication Activity (10 Years)

Top Topics

Top Venues

Amos Akintayo Fatokun (Amos A Fatokun)